Ibutilide exerts a class III antiarrhythmic effect through blocking potassium (IKr/HERG) channels and activating slow delayed inward sodium current that emerges in early repolarisation, and is commonly used for AF termination (34). The gene discussed is KCNH2; the disease is atrial fibrillation.